We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFH icon
1626
Dream Finders Homes
DFH
$1.49B
$1.39M ﹤0.01%
+105,200
New +$1.24M
WAVC.WS
1627
CALL
DELISTED
Waverley Capital Acquisition Corp. 1 Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
WAVC.WS
$1.39M ﹤0.01%
135,095
BRO icon
1628
Brown & Brown
BRO
$24.6B
$1.39M ﹤0.01%
+24,155
New +$1.39M
CVX icon
1629
CALL
Chevron
CVX
$374B
$1.39M ﹤0.01%
8,500
-79,400
-90% -$13.3M
MSAIW icon
1630
CALL
MultiSensor AI Holdings Warrant
MSAIW
$715K
$1.38M ﹤0.01%
132,937
PSTX
1631
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$1.38M ﹤0.01%
448,745
-62,659
-12% -$376K
BLCO icon
1632
Bausch + Lomb
BLCO
$5.92B
$1.38M ﹤0.01%
79,240
+20,995
+36% +$356K
MDY icon
1633
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
$1.38M ﹤0.01%
+3,000
New +$1.4M
ASTL icon
1634
Algoma Steel
ASTL
$463M
$1.37M ﹤0.01%
+169,335
New +$1.29M
CSV icon
1635
Carriage Services
CSV
$648M
$1.36M ﹤0.01%
44,628
-31,938
-42% -$1.01M
BEN icon
1636
Franklin Resources
BEN
$17.3B
$1.35M ﹤0.01%
+50,224
New +$1.47M
EACPW
1637
CALL
DELISTED
Edify Acquisition Corp. Warrant
EACPW
$1.35M ﹤0.01%
129,272
-95,722
-43% -$4.8K
CCTS
1638
DELISTED
Cactus Acquisition Corp. 1 Limited Class A Ordinary Share
CCTS
$1.35M ﹤0.01%
128,934
-210,507
-62% -$2.18M
TREX icon
1639
Trex
TREX
$4.57B
$1.35M ﹤0.01%
27,642
-426,152
-94% -$21.6M
CBD
1640
DELISTED
Companhia Brasileira de Distribuicao
CBD
$1.34M ﹤0.01%
456,876
+328,066
+255% +$1.06M
LIT icon
1641
Global X Lithium & Battery Tech ETF
LIT
$1.46B
$1.34M ﹤0.01%
21,081
+1,069
+5% +$69K
NHICW
1642
CALL
DELISTED
NewHold Investment Corp. II Warrant
NHICW
$1.34M ﹤0.01%
428,748
NBIS
1643
Nebius Group N.V.
NBIS
$43.1B
$1.34M ﹤0.01%
547,676
COKE icon
1644
Coca-Cola Consolidated
COKE
$13B
$1.34M ﹤0.01%
24,970
-45,510
-65% -$2.35M
RTX icon
1645
RTX Corp
RTX
$295B
$1.34M ﹤0.01%
+13,640
New +$1.34M
PRQR icon
1646
ProQR Therapeutics
PRQR
$248M
$1.34M ﹤0.01%
626,926
+206,311
+49% +$631K
TUP
1647
DELISTED
Tupperware Brands Corporation
TUP
$1.33M ﹤0.01%
533,388
+280,572
+111% +$1.03M
PFTAW
1648
CALL
DELISTED
Perception Capital Corp. III Warrant
PFTAW
$1.33M ﹤0.01%
130,298
QSR icon
1649
Restaurant Brands International
QSR
$26B
$1.33M ﹤0.01%
+19,831
New +$1.29M
IVCPW
1650
CALL
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
$1.33M ﹤0.01%
127,686

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.